Baotou Dongbao Bio-Tech Co Ltd (300239) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Baotou Dongbao Bio-Tech Co Ltd (300239) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.19 Million ≈ $1.20 Million USD) by net assets (CN¥1.69 Billion ≈ $247.61 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300239 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Baotou Dongbao Bio-Tech Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Baotou Dongbao Bio-Tech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Baotou Dongbao Bio-Tech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Baotou Dongbao Bio-Tech Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Websol Energy System Limited NSE:WEBELSOLAR	0.338x
Shandong Yuma Sun-shading Technology Corp. Ltd. SHE:300993	0.018x
Coca-Cola Embonor S.A SN:EMBONOR-B	0.050x
Integrated Service Technology TWO:3289	0.067x
Zhejiang Hongchang Electrical Technology Co. Ltd. SHE:301008	0.052x
Ningbo Color Master Batch Co. Ltd. SHE:301019	0.030x
Shenzhen Genvict Technologies Co Ltd SHE:002869	0.005x
Lifestyle Communities Ltd AU:LIC	0.028x

Annual Cash Flow Conversion Efficiency for Baotou Dongbao Bio-Tech Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Baotou Dongbao Bio-Tech Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see Baotou Dongbao Bio-Tech Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.72 Billion ≈ $252.16 Million	CN¥105.92 Million ≈ $15.50 Million	0.061x	+54.67%
2024-12-31	CN¥1.74 Billion ≈ $254.53 Million	CN¥69.13 Million ≈ $10.12 Million	0.040x	-62.26%
2023-12-31	CN¥1.89 Billion ≈ $277.03 Million	CN¥199.39 Million ≈ $29.18 Million	0.105x	-5.32%
2022-12-31	CN¥1.76 Billion ≈ $256.94 Million	CN¥195.32 Million ≈ $28.58 Million	0.111x	+246.38%
2021-12-31	CN¥1.60 Billion ≈ $234.67 Million	CN¥51.50 Million ≈ $7.54 Million	0.032x	-49.22%
2020-12-31	CN¥998.18 Million ≈ $146.07 Million	CN¥63.13 Million ≈ $9.24 Million	0.063x	+250.67%
2019-12-31	CN¥991.86 Million ≈ $145.14 Million	CN¥-41.63 Million ≈ $-6.09 Million	-0.042x	-152.53%
2018-12-31	CN¥750.88 Million ≈ $109.88 Million	CN¥60.00 Million ≈ $8.78 Million	0.080x	+1970.83%
2017-12-31	CN¥729.75 Million ≈ $106.79 Million	CN¥-3.12 Million ≈ $-456.11K	-0.004x	-107.57%
2016-12-31	CN¥718.86 Million ≈ $105.19 Million	CN¥40.54 Million ≈ $5.93 Million	0.056x	-12.57%
2015-12-31	CN¥706.55 Million ≈ $103.39 Million	CN¥45.57 Million ≈ $6.67 Million	0.065x	+279.51%
2014-12-31	CN¥340.56 Million ≈ $49.83 Million	CN¥-12.24 Million ≈ $-1.79 Million	-0.036x	-239.04%
2013-12-31	CN¥351.47 Million ≈ $51.43 Million	CN¥9.08 Million ≈ $1.33 Million	0.026x	+53.46%
2012-12-31	CN¥324.03 Million ≈ $47.42 Million	CN¥5.46 Million ≈ $798.48K	0.017x	-79.42%
2011-12-31	CN¥295.99 Million ≈ $43.31 Million	CN¥24.22 Million ≈ $3.54 Million	0.082x	-15.71%
2010-12-31	CN¥122.44 Million ≈ $17.92 Million	CN¥11.88 Million ≈ $1.74 Million	0.097x	-29.35%
2009-12-31	CN¥100.65 Million ≈ $14.73 Million	CN¥13.83 Million ≈ $2.02 Million	0.137x	+422.49%
2008-12-31	CN¥97.87 Million ≈ $14.32 Million	CN¥-4.17 Million ≈ $-610.07K	-0.043x	--

About Baotou Dongbao Bio-Tech Co Ltd

SHE:300239 China Drug Manufacturers - Specialty & Generic

Market Cap

$475.16 Million

CN¥3.25 Billion CNY

Market Cap Rank

#12671 Global

#3747 in China

Share Price

CN¥5.47

Change (1 day)

+2.24%

52-Week Range

CN¥4.73 - CN¥6.63

All Time High

CN¥9.53